Abstract
Background
The trend of women suffering from early-onset breast cancer is increasing in Taiwan. The association of early-onset breast cancer with body mass index (BMI), menarche, and menopausal status has focused interest on the field of cancer epidemiology; however, few studies have explored the interaction of these factors on early-onset risk. This study aimed to estimate the interaction effects of BMI, menarche, and menopausal status on 40-year-old early-onset breast cancer.
Methods
Breast cancer patients were recruited from Kaohsiung Medical University Chung-Ho Memorial Hospital from 2013 to 2020. Multivariable logistic regression was used to estimate odds ratios (ORs) for early-onset breast cancer risk associated with menarcheal age stratified by sociodemographic factors and for the interaction between BMI and menopausal status on early-onset risk.
Results
A total of 775 participants were divided into 131 early-onset cases (≤ 40 years) and 644 late-onset cases (> 40 years). Compared to the age of 13 years at menarche, the age ≤ 11 years was significantly positively associated (OR: 2.62, 95% CI: 1.38–4.97) and ≥ 16 years was negatively associated (OR: 0.13, 95% CI: 0.03–0.53) with 40-year-old early-onset breast cancer respectively. In an adjusted model, the status of BMI < 24 and premenopause had 1.76- and 4.59-fold risk of early-onset breast cancer respectively. Especially in BMI < 24 status, premenopause also had a 6.47-fold early-onset risk and the early-onset risk increased by a significant amount per one year younger at menarche (aOR: 1.26, 95% CI: 1.03–1.55). There was also a positive interaction effect on an additive scale between BMI and menopausal status on early-onset breast cancer (RERIOR = 4.62, Pinteraction = 0.057). Compared to both BMI ≥ 24 and peri-/postmenopausal status, both the status of BMI < 24 and premenopause were associated with early-onset breast cancer (aOR: 7.16, 95% CI: 3.87–13.25).
Conclusions
This study suggests that the status of BMI < 24 and premenopause were associated with an increased risk of early-onset breast cancer and there was a positive interaction on an additive scale. Understanding how obesity and menopausal status affect early-onset breast cancer is important for drafting preventive measures for early-onset breast cancer in Taiwan.
Keywords: Breast cancer, Early-onset, BMI, Menarche, Menopause, Interaction, Epidemiology
Background
Breast cancer is the most frequently diagnosed cancer at all ages among women, accounting for 24.5% of female cancers, and the burden of breast cancer continues to increase worldwide [1]. In most countries, data in 2018 from the International Agency for Research on Cancer (IARC) showed that age-standardized incidence rate of breast cancer at ages 60–74 years was the highest, but it has reached the highest at 45–59 years of age in Asia. In 2018, data from the Ministry of Health and Welfare (MOHW) in Taiwan showed that the median age at diagnosis of breast cancer was 56 years.
Breast cancer is a multifactorial, heterogeneous, and complex etiology disease. Adiposity, often represented by body mass index (BMI), is an important factor for breast cancer and appears to have opposite effects before and after menopause [2]. Multiple studies have found that higher BMI was positively associated with postmenopausal breast cancer risk [3–5]; however, an inverse association between obesity and breast cancer risk for premenopausal women has been reported [6]. In a large-pooled multicenter study on 758,592 premenopausal women from 19 prospective cohorts, this study also suggested that adiposity was negatively associated with breast cancer [7]. Among genetically susceptible white postmenopausal women, having a healthy lifestyle seem to be associated with decreasing breast cancer risk [8].
The interval between menarche and menopause is generally considered as the female reproductive period, because menarche and menopause refer to the onset and cessation of menstruation separately [9]. In many populations, women tend to have earlier menarcheal age [10–12]; even in Taiwan, the trend of a decline in the age of puberty continues [13]. One study found that the risk of being 45 years old with early-onset breast cancer was higher in women with menarche at 12 years of age compared to women with menarcheal age ≥ 15 years [14]. So far, few studies have explored the association between early-onset breast cancer, BMI, menarche, menopausal status, and other risk factors and the interaction between BMI and menopausal status on early-onset breast cancer.
This study aimed to estimate the association of 40-year-old early-onset breast cancer with BMI, menarche, menopausal status, and sociodemographic risk factors and the interaction effect between BMI and menopausal status on the risk of early-onset breast cancer in Taiwan and whether this could be used to improve early-onset breast cancer risk by some predictive measures during adolescence.
Methods
Study population
From September 2013 to January 2020, this cross-sectional study included 825 female breast cancer patients diagnosed by breast surgeon physicians from Kaohsiung Medical University (KMU) Chung-Ho Memorial Hospital, a medical center in southern Taiwan. Participants were excluded if they had suffered from any other cancers (n = 1), were of foreign ethnicity (n = 1), and had no clinical or questionnaire data (n = 48) (Fig. 1). Finally, 775 breast cancer patients were included in the final analysis and divided into early-onset and late-onset groups based on the age of 40 years at breast cancer diagnosis. The study protocol was approved by the Institutional Review Board (IRB) of Kaohsiung Medical University (KMU) Chung-Ho Memorial Hospital (IRB No. KMUHIRB-20120104, KMUHIRB-20140055, and KMUHIRB-G(I)-20150026). All methods were carried out in accordance with the Declaration of Helsinki. All breast cancer patients provided written informed consents before the interview and biological specimen collection.
Fig. 1.
The flow chart for recruiting female breast cancer participants
Blood and spot morning urine samples were provided from all subjects and self-administered questionnaires were collected by the trained interviewers. The contents about questionnaires included the status of weight, height, education, marriage, the use of alcohol and tobacco, physical activity, age at menarche, menopausal status, the use of oral contraceptives, parity, reproductive age, number of births, lactation history, dietary habits, benign breast disease, the family history of breast cancer, etc. The medical records of patients were followed-up every six months to update information on TNM stage (TNM classification of malignant tumors), cell grade, tumor size, cell invasiveness, the status of hormone receptors, treatment, recurrence, metastasis, and deaths.
Statistical analysis
All participants in this study were divided into early-onset (≤ 40-year-old) and late-onset (> 40-year-old) groups to analyze the differences of continuous and categorical variables by using independent sample t-test, Chi-square test, or Fisher's exact test respectively. Multivariable logistic regression was performed to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between the risk of 40-year-old early-onset breast cancer and sociodemographic risk factors as well as women’s age at menarche and to assess the interaction effect of BMI and menopausal status on early-onset risk. According to the standard classification of the MOHW in Taiwan, BMI was categorized as non-obesity (BMI < 24 kg/m2) and overweight or obesity (BMI ≥ 24 kg/m2). The measurement for interaction effect as additive scale was relative excess risk due to interaction (RERIOR = eβ1+β2+β3—eβ1—eβ2 + 1) [15].
All models were also stratified by the sociodemographic characteristics to assess the risk of 40-year-old early-onset breast cancer in relation to being per one year younger at menarche in women. The adjusted ORs were estimated by adjusting the risk factors that were significantly associated with early-onset breast cancer, including BMI, education, marriage, physical activity, menopausal status, and parity. Because the associations between early-onset breast cancer and twenty-five sociodemographic and clinical characteristics were evaluated at the same time, we used Bonferroni correction (p-value multiplied by twenty-five risk factors) to reduce potential problems (Type I error, also known as a false positive) raised from multiple comparisons. We also performed G*Power to compute statistical power analyses for the multivariable logistic regression [16]. SPSS 22.0 and SAS 9.3 were used to perform all analyses. P-values less than 0.05 were statistically significant.
Results
In Table 1, breast cancer patients are divided into 131 early-onset breast cancer patients (≤ 40 years of age, mean age at diagnosis, 35.87 years) and 644 late-onset breast cancer cases (> 40 years of age, mean age at diagnosis, 54.24 years). Compared with late-onset patients, early-onset patients had more BMI < 24 (76.3%), higher education level (67.2%), were less married (62.6%), more never exercised (51.1%), more premenopausal status (60.3%), more nulliparous (39.7%), just only one child (26.6%), delaying pregnancy beyond the age of 27 years (70.9%), more breastfeeding (73.4%), and preferred to eat fried foods (13.7%). Both early-onset and late-onset groups reflected less than 5.5% in smoking and drinking. After performing Bonferroni correction, most sociodemographic characteristics were still significant, except for physical activity and lactation history. The clinical characteristics of breast cancer are shown in Table 2. Early-onset patients had more extreme breast density (25.4%) compared with late-onset breast cancer patients.
Table 1.
The sociodemographic characteristics between early-onset and late-onset breast cancer participants
| Characteristics, n (%) |
Early-onset (≤ 40 years old) (n = 131) |
Late-onset (> 40 years old) (n = 644) |
P-valuesa | P-values after Bonferroni correction |
|---|---|---|---|---|
| Age at diagnosis (year), mean ± SD | 35.87 ± 4.13 | 54.24 ± 8.68 | < 0.001 | < 0.001 |
| BMI (kg/m2) | < 0.001 | < 0.001 | ||
| BMI < 24 | 100 (76.3) | 361 (56.1) | ||
| BMI ≥ 24 | 31 (23.7) | 282 (43.9) | ||
| Education | < 0.001 | < 0.001 | ||
| < college | 43 (32.8) | 438 (68.0) | ||
| ≥ college | 88 (67.2) | 206 (32.0) | ||
| Marriage | < 0.001 | < 0.001 | ||
| Unmarried/Divorce/Widowed | 49 (37.4) | 125 (19.4) | ||
| Married | 82 (62.6) | 519 (80.6) | ||
| Smoking state | 0.677 | 1.000 | ||
| Never | 124 (94.7) | 615 (95.5) | ||
| Ever | 7 (5.3) | 29 (4.5) | ||
| Alcohol intake | 1.000 | 1.000 | ||
| Never | 128 (97.7) | 627 (97.4) | ||
| Ever | 3 (2.3) | 17 (2.6) | ||
| Physical activity | 0.035 | 0.875 | ||
| None | 67 (51.1) | 265 (41.1) | ||
| Yes | 64 (48.9) | 379 (58.9) | ||
| Menopausal status | < 0.001 | < 0.001 | ||
| Premenopause | 79 (60.3) | 108 (16.8) | ||
| Peri-/Postmenopause | 52 (39.7) | 536 (83.2) | ||
| BMI < 24 | < 0.001 | < 0.001 | ||
| Premenopause | 67 (67.0) | 65 (18) | ||
| Peri-/Postmenopause | 33 (33.0) | 296 (82) | ||
| BMI ≥ 24 | 0.001 | 0.025 | ||
| Premenopause | 12 (38.7) | 43 (15.2) | ||
| Peri-/Postmenopause | 19 (61.3) | 239 (84.8) | ||
| Oral contraceptive use | 0.149 | 1.000 | ||
| Never | 119 (90.8) | 555 (86.2) | ||
| Ever | 12 (9.2) | 89 (13.8) | ||
| Parity | < 0.001 | < 0.001 | ||
| Nulliparous | 52 (39.7) | 79 (12.3) | ||
| Parous | 79 (60.3) | 565 (87.7) | ||
| Number of births | 0.001 | 0.025 | ||
| One | 21 (26.6) | 72 (12.7) | ||
| More than one | 58 (73.4) | 493 (87.3) | ||
| Age at first birth | < 0.001 | 0.001 | ||
| < 27 years | 23 (29.1) | 303 (53.7) | ||
| ≥ 27 years | 56 (70.9) | 261 (46.3) | ||
| Lactation history | 0.003 | 0.075 | ||
| Never | 21 (26.6) | 251 (44.4) | ||
| Ever | 58 (73.4) | 314 (55.6) | ||
| Fried food | < 0.001 | < 0.001 | ||
| 1 ~ 2 times a week | 113 (86.3) | 619 (96.1) | ||
| 3 ~ 6 times a week | 18 (13.7) | 25 (3.9) | ||
| Benign breast disease | 0.559 | 1.000 | ||
| Never | 98 (74.8) | 497 (77.2) | ||
| Ever | 33 (25.2) | 147 (22.8) | ||
| Family history of BC | 0.073 | 1.000 | ||
| None | 96 (73.3) | 517 (80.3) | ||
| Yes | 35 (26.7) | 127 (19.7) |
SD Standard deviation, BMI Body mass index
aP-values were calculated for continuous variables by Independent sample t-test and for categorical variables by Chi-square test or Fisher's exact test
Table 2.
The clinical characteristics between early-onset and late-onset breast cancer participants
| Characteristics, n (%) |
Early-onset (≤ 40 years old) (n = 131) |
Late-onset (> 40 years old) (n = 644) |
P-valuesa | P-values after Bonferroni correction |
|---|---|---|---|---|
| Breast density | < 0.001 | 0.0048 | ||
| Fatty + Mildly dense | 10 (7.9) | 99 (16.5) | ||
| Moderately | 84 (66.7) | 426 (71.0) | ||
| Extremely | 32 (25.4) | 75 (12.5) | ||
| Molecular subtype | 0.322 | 1.000 | ||
| Luminal A | 78 (65.5) | 379 (62.0) | ||
| Luminal B | 22 (18.5) | 107 (17.5) | ||
| HER2-enriched | 7 (5.9) | 71 (11.6) | ||
| Triple negative | 12 (10.1) | 54 (8.8) | ||
| TNM stage | 0.822 | 1.000 | ||
| 0/I/II | 108 (84.4) | 529 (83.6) | ||
| III/IV | 20 (15.6) | 104 (16.4) | ||
| Grade | 0.761 | 1.000 | ||
| Well differentiated | 16 (13.7) | 85 (13.8) | ||
| Moderately differentiated | 65 (55.6) | 321 (52.1) | ||
| Poorly differentiated | 36 (30.8) | 210 (34.1) | ||
| Tumor size | 0.251 | 1.000 | ||
| ≤ 2 cm | 68 (54.4) | 371 (59.9) | ||
| > 2 cm | 57 (45.6) | 248 (40.1) | ||
| Invasive | 0.055 | 1.000 | ||
| None | 9 (8.9) | 91 (16.4) | ||
| Yes | 92 (91.1) | 465 (83.6) | ||
| ER status | 0.272 | 1.000 | ||
| ER-negative | 22 (17.5) | 138 (21.8) | ||
| ER-positive | 104 (82.5) | 494 (78.2) | ||
| PR status | 0.270 | 1.000 | ||
| PR-negative | 37 (29.8) | 220 (35.0) | ||
| PR-positive | 87 (70.2) | 409 (65.0) | ||
| HER2 status | 0.292 | 1.000 | ||
| HER2-negative | 90 (75.6) | 433 (70.9) | ||
| HER2-positive | 29 (24.4) | 178 (29.1) |
TNM stage TNM classification of malignant tumors, ER Estrogen receptor, PR Progesterone receptor, HER2 Human epidermal growth factor receptor 2. aP-values were calculated for categorical variables by Chi-square test
Compared to the age of 13 years at menarche, the age ≤ 11 years was significantly associated with early-onset breast cancer at the age of 40 years (OR = 2.62, 95% CI: 1.38–4.97, p-value = 0.003) and the age ≥ 16 years was significantly associated with decreased risk of 40-year-old early-onset breast cancer (OR = 0.13, 95% CI: 0.03–0.53, p-value = 0.005). As the age at menarche increased, the risk of early-onset breast cancer decreased (Fig. 2).
Fig. 2.
The risk of 40-years-old early-onset breast cancer by per age at menarche. The black dots represent the odds ratios (ORs) for the risk of 40-years-old early-onset breast cancer by per age at menarche and the vertical dotted lines represent 95% confidence intervals (CIs)
The adjusted models in Table 3, the status of BMI < 24, higher education level, premenopause, nulliparity, and breastfeeding were associated with increased risks of 40-year-old early-onset breast cancer, with aORs ranging from 1.76 to 4.59. Compared to BMI ≥ 24 status, BMI < 24 status was positively associated with early-onset breast cancer (aOR = 1.76, 95% CI: 1.09–2.84, p-value = 0.020); especially in the status of BMI < 24, the risk of early-onset breast cancer significantly increased by being per one year younger at menarche (aOR: 1.26, 95% CI: 1.03–1.55, p-value = 0.028). In the stratification of the sociodemographic characteristics, including the status of BMI < 24, higher education level, peri-/postmenopause, parous, and breastfeeding, by being per one year younger at menarche, the aORs of 40-year-old early-onset breast cancer were 1.26 to 1.38 with statistical significance. Premenopausal status was associated with 40-year-old early-onset breast cancer (aOR = 4.59, 95% CI: 2.97–7.16, p-value < 0.001) compared with peri-/postmenopausal status; especially in the status of BMI < 24, the association between premenopausal status and early-onset breast cancer was also significantly positive (aOR = 6.47, 95% CI: 3.76–11.13, p-value < 0.001).
Table 3.
The association of 40-year-old early-onset breast cancer with sociodemographic characteristics and correlated with menarcheal age
| The risk of 40-year-old early-onset breast cancer | The risk of early-onset breast cancer by per 1 year younger at menarche | The risk of 40-year-old early-onset breast cancer | The risk of early-onset breast cancer by per 1 year younger at menarche | |||||
|---|---|---|---|---|---|---|---|---|
| Characteristics | cOR (95% CI)a | P-values | cOR (95% CI)a | P-values | aOR (95% CI)b | P-values | aOR (95% CI)b | P-values |
| BMI (kg/m2) | ||||||||
| BMI < 24 | 2.52 (1.64–3.88) | < 0.001 | 1.49 (1.24–1.78) | < 0.001 | 1.76 (1.09–2.84) | 0.020 | 1.26 (1.03–1.55) | 0.028 |
| BMI ≥ 24 | 1 | 1.41 (1.09–1.83) | 0.008 | 1 | 1.23 (0.92–1.63) | 0.162 | ||
| Education | ||||||||
| < college | 1 | 1.20 (0.96–1.50) | 0.110 | 1 | 1.15 (0.89–1.47) | 0.282 | ||
| ≥ college | 4.35 (2.92–6.50) | < 0.001 | 1.36 (1.12–1.65) | 0.002 | 2.54 (1.62–3.98) | < 0.001 | 1.30 (1.04–1.62) | 0.022 |
| Marriage | ||||||||
| Unmarried/Divorce/Widowed | 2.48 (1.66–3.72) | < 0.001 | 1.28 (0.98–1.67) | 0.066 | 0.88 (0.44–1.77) | 0.726 | 1.05 (0.78–1.40) | 0.749 |
| Married | 1 | 1.49 (1.25–1.77) | < 0.001 | 1 | 1.32 (1.08–1.61) | 0.008 | ||
| Physical activity | ||||||||
| None | 1.50 (1.03–2.18) | 0.036 | 1.45 (1.18–1.78) | < 0.001 | 1.40 (0.90–2.17) | 0.138 | 1.27 (0.99–1.62) | 0.058 |
| Yes | 1 | 1.37 (1.13–1.67) | 0.001 | 1 | 1.20 (0.96–1.51) | 0.113 | ||
| Menopausal status | ||||||||
| Premenopause | 7.54 (5.02–11.32) | < 0.001 | 1.09 (0.87–1.37) | 0.436 | 4.59 (2.94–7.16) | < 0.001 | 1.12 (0.86–1.46) | 0.397 |
| Peri-/Postmenopause | 1 | 1.39 (1.13–1.71) | 0.002 | 1 | 1.35 (1.09–1.69) | 0.007 | ||
| BMI < 24 | ||||||||
| Premenopause | 9.25 (5.63–15.18) | < 0.001 | 1.20 (0.91–1.59) | 0.205 | 6.47 (3.76–11.13) | < 0.001 | 1.12 (0.83–1.51) | 0.446 |
| Peri-/Postmenopause | 1 | 1.45 (1.09–1.92) | 0.010 | 1 | 1.42 (1.05–1.91) | 0.022 | ||
| BMI ≥ 24 | ||||||||
| Premenopause | 3.51 (1.59–7.75) | 0.002 | 1.22 (0.74–2.02) | 0.435 | 2.18 (0.93–5.12) | 0.073 | 1.28 (0.67–2.42) | 0.457 |
| Peri-/Postmenopause | 1 | 1.34 (0.98–1.84) | 0.067 | 1 | 1.27 (0.91–1.78) | 0.161 | ||
| Parity | ||||||||
| Nulliparous | 4.71 (3.09–7.18) | < 0.001 | 1.18 (0.91–1.53) | 0.220 | 3.10 (1.53–6.29) | 0.002 | 1.01 (0.75–1.36) | 0.964 |
| Parous | 1 | 1.52 (1.27–1.81) | < 0.001 | 1 | 1.33 (1.09–1.62) | 0.005 | ||
| Number of births | ||||||||
| One | 2.48 (1.42–4.33) | 0.001 | 1.73 (1.14–2.63) | 0.011 | 1.60 (0.85–3.01) | 0.149 | 1.59 (0.99–2.53) | 0.054 |
| More than one | 1 | 1.46 (1.20–1.78) | < 0.001 | 1 | 1.28 (1.02–1.60) | 0.033 | ||
| Age at first birth | ||||||||
| < 27 years | 1 | 1.33 (0.99–1.79) | 0.060 | 1 | 1.19 (0.85–1.67) | 0.318 | ||
| ≥ 27 years | 2.83 (1.69–4.72) | < 0.001 | 1.52 (1.21–1.91) | < 0.001 | 1.28 (0.70–2.33) | 0.421 | 1.35 (1.04–1.73) | 0.022 |
| Lactation history | ||||||||
| Never | 1 | 1.29 (0.91–1.83) | 0.148 | 1 | 1.21 (0.83–1.76) | 0.333 | ||
| Ever | 2.21 (1.31–3.74) | 0.003 | 1.62 (1.32–1.99) | < 0.001 | 1.87 (1.06–3.28) | 0.030 | 1.38 (1.09–1.76) | 0.008 |
| Fried food | ||||||||
| 1 ~ 2 times a week | 1 | 1.32 (1.14–1.53) | < 0.001 | 1 | 1.19 (1.00–1.41) | 0.055 | ||
| 3 ~ 6 times a week | 3.94 (2.08–7.47) | < 0.001 | 1.72 (1.10–2.70) | 0.019 | 1.97 (0.91–4.26) | 0.085 | 1.20 (0.47–3.04) | 0.707 |
| Benign breast disease | ||||||||
| Never | 1 | 1.37 (1.17–1.61) | < 0.001 | 1 | 1.17 (0.96–1.42) | 0.117 | ||
| Ever | 1.14 (0.74–1.76) | 0.559 | 1.53 (1.16–2.03) | 0.003 | 1.11 (0.68–1.83) | 0.670 | 1.44 (1.03–2.00) | 0.031 |
| Family history of BC | ||||||||
| None | 1 | 1.36 (1.16–1.60) | < 0.001 | 1 | 1.20 (0.99–1.46) | 0.062 | ||
| Yes | 1.48 (0.96–2.29) | 0.074 | 1.56 (1.15–2.11) | 0.004 | 1.43 (0.87–2.36) | 0.163 | 1.32 (0.92–1.91) | 0.133 |
BMI body mass index, OR odds ratio, CI confidence interval
aCrude odds ratio (cOR) was calculated by multivariable logistic regression
bAdjusted for BMI, education, marriage, physical activity, menopausal status, and parity, shown as aOR (95% CI)
There was also a positive interaction effect on an additive scale between BMI and menopausal status on 40-year-old early-onset breast cancer (RERIOR = 4.62, Pinteraction = 0.057), shown in Fig. 3. Compared to both the status of BMI ≥ 24 and peri-/postmenopause, both BMI < 24 and premenopausal status were significantly associated with early-onset breast cancer (aOR = 7.16, 95% CI: 3.87–13.25, p-value < 0.001). Furthermore, in the statistical power analyses for the two important variables of BMI and menopausal status, the statistical power was 87.78% and 100% respectively.
Fig. 3.
The interaction effect between BMI and menopausal status on 40-year-old early-onset breast cancer risk. Odds ratios (ORs) were calculated by multivariable logistic regression and adjusted for education, marriage, physical activity, and parity. The vertical dotted lines represent 95% confidence intervals (CIs). *P-values < 0.05, **P-values < 0.01
Discussion
In this 40-year-old early-onset breast cancer study in southern Taiwan, various potential factors were associated with early-onset breast cancer, including the status of BMI < 24, premenopause, high education level, nulliparity, and breastfeeding. There was also a positive interaction on an additive scale between BMI and menopausal status; with both the status of BMI < 24 and premenopause, the risk of 40-year-old early-onset breast cancer was more significant, and especially for BMI < 24 status, early-onset breast cancer risk increased by being per one year younger at menarche.
A meta study also analyzed the relationship between sociodemographic, reproductive factor, menarche, menopause, and breast cancer [9], and found that decreasing BMI might enhance the association between breast cancer risk and age at menarche among both premenopausal and postmenopausal women, and was especially significant in postmenopausal women, which was similar to our findings. In our study, in the status of peri-/postmenopause, BMI < 24 status significantly enhanced the association between early-onset breast cancer and age at menarche per one year younger. In our study, high education level was positively associated with early-onset breast cancer and the risk increased for being one year younger at menarche in this status. Higher education level might be associated with increasing breast cancer risk in a meta-analysis of 18 cohort studies [17] and appeared mediated by nulliparity and later menopausal age [18]. The mean age at the onset of breast cancer in Iranian women was about 10 years lower than other developed countries [19]. A hospital‐based case–control study in Iranian young women found that low parity was associated with breast cancer [20] and our study also suggested that nulliparity was related to a higher risk of early-onset breast cancer.
Because this study was about early-onset breast cancer, the premenopausal status accounted for 60.3% of early-onset cases and increased 4.59-fold risk of the early-onset breast cancer; furthermore, both the status of BMI < 24 and premenopause, the risk of early-onset breast cancer was more significant with 7.16-fold risk. Understanding how obesity affects early-onset breast cancer is also an important public health issue. Being overweight or obese in adulthood is associated with increased risks of postmenopausal breast cancer, colorectal cancer, kidney cancer, liver cancer, and pancreatic cancer. For breast cancer, obesity in adulthood is inversely associated with the risk of premenopausal breast cancer but increases the postmenopausal breast cancer risk [21]. Our study also found that both the status of BMI < 24 and premenopause were significantly associated with the increased risk of 40-year-old early-onset breast cancer. The inverse association between BMI and breast cancer risk among premenopausal women has been reported in multiple studies [6, 7, 22, 23], and a significant inverse association has been found between total estradiol concentration and BMI in premenopausal women [24–26]. The biosynthesis of estrogens differs between premenopausal and postmenopausal women. The ovary is the main source of estrogens synthesis in premenopausal women; however, after menopause, peripheral site synthesis replaces ovarian biosynthesis, and for obese postmenopausal women, peripheral aromatization of androgens in adipose tissues is the main source [27, 28]. In premenopausal women, estrogen is synthesized from androgens through the aromatase enzyme in peripheral tissues (principally subcutaneous fat) contributing about 5% of the total plasma estradiol synthesis across the menstrual cycle [7, 29]. The several mechanisms for the inverse association between BMI and breast cancer in premenopausal status are as follows. In normal weight premenopausal women, breast cells are exposed to steroidal estrogens via complex feedback-controlled [29]; however, in obese premenopausal women, higher estrogen levels produced from adipose tissues activate negative feedback in the hypothalamic-pituitary-axis leading to a decrease in circulating hormones, switching off normal ovarian function, and inducing amenorrhea while being associated with decreased risk of breast cancer [29, 30]. Obese premenopausal women may exhibit greater degree of ovulatory insufficiency and this irregular menstrual cycle might result in lower levels of estradiol and progesterone as well as lower breast cancer risk [24, 31–34].
Circulating sex hormones such as estradiol and testosterone are mainly bound to sex hormone-binding globulin (SHBG) produced by the liver. The levels of free circulating sex hormones decrease and lose bioavailability by binding SHBG [35]. Studies have found that SHBG decreased with increasing BMI [24, 25] in premenopausal and postmenopausal healthy women [26, 36]. A study of premenopausal women in the Nurses’ Health Study II found that adult BMI, even current BMI, was strongly negatively related to the levels of SHBG and total estrogen and suggested the inverse association between BMI and premenopausal breast cancer might possibly be mediated in part by sex hormones [34]. With the decline of SHBG, free estradiol should increase; however, the hypothalamic-pituitary-axis still maintains regulatory control of free estradiol levels in premenopausal women [34, 37]. In premenopausal women, estradiol concentrations and SHBG levels decreased with increasing BMI; lower estradiol levels are the result of increased estradiol clearance due to reduced serum-hormone binding capacity [6, 24, 36]. However, lower SHBG and higher estradiol were associated with obesity in postmenopausal women [38, 39], while the levels of SHBG appeared inversely related to breast cancer risk in postmenopausal women [40–42]. The above biological mechanisms might be possible explanations for the negative correlation between BMI and early-onset breast cancer in premenopausal status in our study; however, women are not encouraged to gain weight as a preventative measure against early-onset breast cancer. Further studies are required to explore the relationship between the risk of early-onset breast cancer, obesity, sex hormones, and ovarian function.
Insulin-like growth factor 1 (IGF-1) is important for the development and function of many tissues, including promoting cell proliferation and inhibiting apoptosis [43, 44]. Early-adulthood body size is associated with IGF-1, an intermediate marker for breast cancer, and overweight women have lower IGF-1 levels than lean women in youth and adolescence [45]. Many studies have suggested that IGF-1 is involved in the development of breast cancer [46–48], is associated with an increased risk of premenopausal breast cancer [49], and has poor prognosis [50] including decreased breast cancer-specific survival [51]. IGF-1 could also explain the negative correlation between BMI and early-onset breast cancer in premenopausal status of this study.
Obesity has adverse effects on health [52], although our results suggested that the risk of early-onset breast cancer with BMI < 24 status was greater than that with BMI ≥ 24 and, especially in BMI < 24 status, the risk was significantly increased by being per one year younger at menarche; however, gaining weight is not recommended as a way to decrease early-onset breast cancer risk. Our study also indicated that intake of fried food was borderline significantly associated with an increased risk of early-onset breast cancer in the adjusted model. Consumption of fried foods has also been reported to be associated with breast cancer [53], while unhealthy dietary patterns such as consumption of fried food and sugar-sweetened soft drinks appear associated with earlier menarche [54, 55]. In addition, our study found that breastfeeding increased early-onset breast cancer risk, which might explain early detection of breast cancer due to breastfeeding.
There are some limitations in our study. Firstly, this study was a cross-sectional study, so the causation of BMI status for early-onset breast cancer was difficult to clarify; however, the results of age at menarche were credible. Age at menarche occurs before breast cancer occurrence. Secondly, no environmental exposure issues were included in the questionnaire. These factors could be also related to the occurrence of breast cancer and might have interfered with the results in the study. Thirdly, Type I error was raised from multiple comparisons between early-onset breast cancer and several sociodemographic and clinical factors. Bonferroni correction was used to reduce potential problems and most sociodemographic characteristics remained statistically significant results. Furthermore, after adjusting for these confounding factors, there was a positive interaction effect on an additive scale between BMI and menopausal status on early-onset breast cancer.
Conclusions
These findings suggested that younger age at menarche, BMI < 24 status, and premenopausal status were related to 40-year-old early-onset breast cancer and there was a positive interaction effect on an additive scale between the status of BMI < 24 and premenopause on early-onset breast cancer. Therefore, maintaining proper weight before menopause and keeping good dietary habits to prevent precocious puberty could both be beneficial to decrease the risk of early-onset breast cancer. Understanding the mechanism of the inverse association between BMI status and the risk of premenopausal early-onset breast cancer could possible modify the pathways. The results of this study require larger sample size to differentiate incident and prevalent patients with early-onset breast cancer to explore cause-and-effect relationships and perform a prospective study design to elucidate this biochemical mechanism.
Acknowledgements
We would like to thank all the subjects who participated in this study.
Abbreviations
- IARC
International Agency for Research on Cancer
- MOHW
Ministry of Health and Welfare
- BMI
Body mass index
- KMU
Kaohsiung Medical University
- IRB
Institutional Review Board
- TNM stage
TNM classification of malignant tumors
- ORs
Odds ratios
- CIs
Confidence intervals
- RERI
Relative excess risk due to interaction
- SHBG
Sex hormone-binding globulin
- IGF-1
Insulin-like growth factor 1
Authors' contributions
PJY: Conceptualization, Data curation, Formal analysis, Writing—original draft, Writing—review & editing. MFH: Investigation, Resources. FOY: Investigation, Resources. EMT: Funding acquisition, Resources, Supervision. TNW: Conceptualization, Funding acquisition, Methodology, Resources, Supervision, Writing—review & editing. All authors have read and approved the manuscript.
Funding
The work was supported by the National Science Council of Taiwan (NSC 102–2632-B-037–001-MY3), and partially from the Kaohsiung Medical University ‘Aim for the Top Universities Grant’ (KMU-TP103A16, KMU-TP104A01, and KMU-TP105A05). The funding sources had no role in the study design, data collection, data analysis, data interpretation, writing of the manuscript, or decision to submit the article for publication.
Availability of data and materials
All data generated or analysed during this study are included in this published article.
Declarations
Ethics approval and consent to participate
The study protocol was approved by the Institutional Review Board (IRB) of Kaohsiung Medical University (KMU) Chung-Ho Memorial Hospital (IRB No. KMUHIRB-20120104, KMUHIRB-20140055, and KMUHIRB-G(I)-20150026). All methods were carried out in accordance with the Declaration of Helsinki. All breast cancer patients provided written informed consents before the interview and biological specimen collection.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 2.Chen Y, Liu L, Zhou Q, Imam MU, Cai J, Wang Y, et al. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies. BMC Public Health. 2017;17(1):936. doi: 10.1186/s12889-017-4953-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol. 2015;1(5):611–621. doi: 10.1001/jamaoncol.2015.1546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.White AJ, Nichols HB, Bradshaw PT, Sandler DP. Overall and central adiposity and breast cancer risk in the Sister Study. Cancer. 2015;121(20):3700–3708. doi: 10.1002/cncr.29552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–578. doi: 10.1016/s0140-6736(08)60269-x. [DOI] [PubMed] [Google Scholar]
- 6.van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–527. doi: 10.1093/aje/152.6.514. [DOI] [PubMed] [Google Scholar]
- 7.Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, et al. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncol. 2018;4(11):e181771. doi: 10.1001/jamaoncol.2018.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Al Ajmi K, Lophatananon A, Mekli K, Ollier W, Muir KR. Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort. JAMA Netw Open. 2020;3(4):e203760. doi: 10.1001/jamanetworkopen.2020.3760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Collaborative Group on Hormonal Factors in Breast Cancer Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13(11):1141–1151. doi: 10.1016/s1470-2045(12)70425-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev. 2003;24(5):668–693. doi: 10.1210/er.2002-0019. [DOI] [PubMed] [Google Scholar]
- 11.Pierce M, Hardy R. Commentary: The decreasing age of puberty–as much a psychosocial as biological problem? Int J Epidemiol. 2012;41(1):300–302. doi: 10.1093/ije/dyr227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Herman-Giddens ME. The decline in the age of menarche in the United States: should we be concerned? J Adolesc Health. 2007;40(3):201–203. doi: 10.1016/j.jadohealth.2006.12.019. [DOI] [PubMed] [Google Scholar]
- 13.Chow JC, Chou TY, Tung TH, Yuh YS. Recent pubertal timing trends in Northern Taiwanese children: Comparison with skeletal maturity. J Chin Med Assoc. 2020;83(9):870–875. doi: 10.1097/jcma.0000000000000360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Butler LM, Potischman NA, Newman B, Millikan RC, Brogan D, Gammon MD, Swanson CA, Brinton LA. Menstrual risk factors and early-onset breast cancer. Cancer Causes Control. 2000;11(5):451–458. doi: 10.1023/a:1008956524669. [DOI] [PubMed] [Google Scholar]
- 15.Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36(5):1111–1118. doi: 10.1093/ije/dym157. [DOI] [PubMed] [Google Scholar]
- 16.Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. doi: 10.3758/brm.41.4.1149. [DOI] [PubMed] [Google Scholar]
- 17.Dong JY, Qin LQ. Education level and breast cancer incidence: a meta-analysis of cohort studies. Menopause. 2020;27(1):113–118. doi: 10.1097/gme.0000000000001425. [DOI] [PubMed] [Google Scholar]
- 18.Heck KE, Pamuk ER. Explaining the relation between education and postmenopausal breast cancer. Am J Epidemiol. 1997;145(4):366–372. doi: 10.1093/oxfordjournals.aje.a009114. [DOI] [PubMed] [Google Scholar]
- 19.Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, Ebrahimi M. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13(4):383–391. doi: 10.1111/j.1524-4741.2007.00446.x. [DOI] [PubMed] [Google Scholar]
- 20.Ghiasvand R, Maram ES, Tahmasebi S, Tabatabaee SH. Risk factors for breast cancer among young women in southern Iran. Int J Cancer. 2011;129(6):1443–1449. doi: 10.1002/ijc.25748. [DOI] [PubMed] [Google Scholar]
- 21.Wild CP, Weiderpass E, Stewart BW. World Cancer Report: Cancer Research for Cancer Prevention. chapter 2.7, chapter 3.6, chapter 5.9. International Agency for Research on Cancer (IARC); 2020.
- 22.Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166(21):2395–2402. doi: 10.1001/archinte.166.21.2395. [DOI] [PubMed] [Google Scholar]
- 23.Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, et al. A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1532–1544. doi: 10.1158/1055-9965.Epi-10-0025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996;88(11):756–758. doi: 10.1093/jnci/88.11.756. [DOI] [PubMed] [Google Scholar]
- 25.Randolph JF, Jr, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab. 2003;88(4):1516–1522. doi: 10.1210/jc.2002-020777. [DOI] [PubMed] [Google Scholar]
- 26.Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom) Cancer Causes Control. 2001;12(1):47–59. doi: 10.1023/a:1008929714862. [DOI] [PubMed] [Google Scholar]
- 27.Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology. 2009;150(6):2537–2542. doi: 10.1210/en.2009-0070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer. 2006;13(2):279–292. doi: 10.1677/erc.1.00729. [DOI] [PubMed] [Google Scholar]
- 29.Dowsett M, Folkerd E. Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis. Breast Cancer Res Treat. 2015;149(1):1–4. doi: 10.1007/s10549-014-3211-4. [DOI] [PubMed] [Google Scholar]
- 30.Polotsky AJ, Hailpern SM, Skurnick JH, Lo JC, Sternfeld B, Santoro N. Association of adolescent obesity and lifetime nulliparity–the Study of Women's Health Across the Nation (SWAN) Fertil Steril. 2010;93(6):2004–2011. doi: 10.1016/j.fertnstert.2008.12.059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35. doi: 10.1093/oxfordjournals.epirev.a036102. [DOI] [PubMed] [Google Scholar]
- 32.Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994;171(1):171–177. doi: 10.1016/0002-9378(94)90465-0. [DOI] [PubMed] [Google Scholar]
- 33.Oh H, Boeke CE, Tamimi RM, Smith-Warner SA, Wang M, Willett WC, Eliassen AH. The interaction between early-life body size and physical activity on risk of breast cancer. Int J Cancer. 2015;137(3):571–581. doi: 10.1002/ijc.29272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tworoger SS, Eliassen AH, Missmer SA, Baer H, Rich-Edwards J, Michels KB, Barbieri RL, Dowsett M, Hankinson SE. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2494–2501. doi: 10.1158/1055-9965.Epi-06-0671. [DOI] [PubMed] [Google Scholar]
- 35.Thompson DJ, Healey CS, Baynes C, Kalmyrzaev B, Ahmed S, Dowsett M, et al. Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3490–3498. doi: 10.1158/1055-9965.Epi-08-0734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004;150(2):161–171. doi: 10.1530/eje.0.1500161. [DOI] [PubMed] [Google Scholar]
- 37.Mishell D, Yen S, Jaffe R, Barbieri R. Reproductive Endocrinology, Physiology, Pathophysiology, and Clinical Management. Philadelphia: WB Saunders Co.; 1999. [Google Scholar]
- 38.Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, Ouyang P, Vaidya D. Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. Clin Gastroenterol Hepatol. 2015;13(9):1686–93.e1682. doi: 10.1016/j.cgh.2014.12.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Vaidya D, Dobs A, Gapstur SM, Golden SH, Hankinson A, Liu K, Ouyang P. The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis. Metabolism. 2008;57(6):782–790. doi: 10.1016/j.metabol.2008.01.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer. 2005;12(4):1071–1082. doi: 10.1677/erc.1.01038. [DOI] [PubMed] [Google Scholar]
- 41.Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94(8):606–616. doi: 10.1093/jnci/94.8.606. [DOI] [PubMed] [Google Scholar]
- 42.Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I, et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer. 2004;90(1):153–159. doi: 10.1038/sj.bjc.6601517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915–928. doi: 10.1038/nrc2536. [DOI] [PubMed] [Google Scholar]
- 44.Kooijman R. Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev. 2006;17(4):305–323. doi: 10.1016/j.cytogfr.2006.02.002. [DOI] [PubMed] [Google Scholar]
- 45.Poole EM, Tworoger SS, Hankinson SE, Schernhammer ES, Pollak MN, Baer HJ. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol. 2011;174(6):642–651. doi: 10.1093/aje/kwr123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Tong Y, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients. Front Oncol. 2020;10:550. doi: 10.3389/fonc.2020.00550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lann D, LeRoith D. The role of endocrine insulin-like growth factor-I and insulin in breast cancer. J Mammary Gland Biol Neoplasia. 2008;13(4):371–379. doi: 10.1007/s10911-008-9100-x. [DOI] [PubMed] [Google Scholar]
- 48.Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010;11(6):530–542. doi: 10.1016/s1470-2045(10)70095-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363(9418):1346–1353. doi: 10.1016/s0140-6736(04)16044-3. [DOI] [PubMed] [Google Scholar]
- 50.Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015;14:43. doi: 10.1186/s12943-015-0291-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Duggan C, Wang CY, Neuhouser ML, Xiao L, Smith AW, Reding KW, et al. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int J Cancer. 2013;132(5):1191–1200. doi: 10.1002/ijc.27753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13–27. doi: 10.1056/NEJMoa1614362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Dai Q, Shu XO, Jin F, Gao YT, Ruan ZX, Zheng W. Consumption of animal foods, cooking methods, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2002;11(9):801–808. [PubMed] [Google Scholar]
- 54.Chen C, Chen Y, Zhang Y, Sun W, Jiang Y, Song Y, et al. Association between Dietary Patterns and Precocious Puberty in Children: A Population-Based Study. Int J Endocrinol. 2018;2018:4528704. doi: 10.1155/2018/4528704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Carwile JL, Willett WC, Spiegelman D, Hertzmark E, Rich-Edwards J, Frazier AL, Michels KB. Sugar-sweetened beverage consumption and age at menarche in a prospective study of US girls. Hum Reprod. 2015;30(3):675–683. doi: 10.1093/humrep/deu349. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analysed during this study are included in this published article.